Coffee & Compatibility

Discussion on the development of Machine Learning approaches and advancements within the ML/AI technology towards application with transplantation.

Check out this live recording of Coffee & Compatibility from the 2022 ASHI Annual Meeting. Podcast hosts Drs. Eric Weimer and Kelley Hitchman interview ASHI's CEO Ms. Katherine Giovetsis, Dr. Peter Lalli, Dr. Luis Hidalgo, and Ms. Carey Killion.

In this episode, Mr. James Nguyen, a Principal Cloud Solution Architect at Microsoft Azure, discusses the application and design of machine learning approaches to healthcare. He talks about how applying his years of experience with big data analytics to modern healthcare challenges can aid in the solution of complex challenges. Topics will include data engineering, data quality, and most importantly, how to get started.

HLA Innovators Dr. Robert Liwski, Dr. Annette Jackson and Dr. Anne Halpin set the stage for best practices in anti-HLA antibody testing and analysis on this special Coffee & Compatibility Episode. You do not want to miss this episode or the related session at this year’s ASHI annual meeting in Las Vegas, NV October 24-28.

Join us and Dr. Matthieu-P. Schapranow of the NephroCAGE consortium, for an episode dedicated to the application of artificial intelligence and machine learning in transplant risk assessment.

In this short episode, we interviewed ASHI's government liaison representation Mr. James Fleischmann of Wheat-Shroyer Government Relations firm and ASHI Board Member Dr. Cathi Murphy to discuss concerns regarding the VALID Act and what you can do to help.

In this very salient episode, Dr. Yvette Miller guides us through current concerns in Sickle Cell Disease, the dire need for African American blood donor recruitment and the needs for the medical community to work harder to earn trust, and focus equity and access, in disadvantaged populations.

Join us for the third and final episode of our series on the progress of the Sensitization in Transplantation: Assessment of Risk (STAR) workgroup. Dr. Michelle Hickey joins us to discuss perhaps the newest and most controversial STAR workgroup sub-study, non-HLA antibody testing and diagnostics.

Join us for the second episode of our series on the progress of the Sensitization in Transplantation: Assessment of Risk (STAR) workgroup. During this second episode of the STAR workgroup series we are joined by Dr. David Pinelli for a discussion on alloimmunity and diagnostics.

Join us for the first in a multi-episode series on the progress of the Sensitization in Transplantation: Assessment of Risk (STAR) workgroup. In the first episode of the STAR workgroup series, we discuss progress in the utility of anti-HLA antibody testing in clinical trials with Dr. Nicole Valenzuela.